George A. Newcomb - 03 Jan 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
Chief Accounting Officer
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Issuer symbol
GEHC
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 19:39:14 UTC
Previous filing
14 Dec 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common stock, par value $0.01 per share Award +439 439 03 Jan 2023 Direct F1
transaction GEHC Common stock, par value $0.01 per share Award +12 12 03 Jan 2023 By family member F1
transaction GEHC Common stock, par value $0.01 per share Award +143 143 03 Jan 2023 401(k) F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award +3,672 3,672 04 Jan 2023 Common stock, par value $0.01 per share 3,672 $129.52 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +3,672 3,672 04 Jan 2023 Common stock, par value $0.01 per share 3,672 $142.15 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +3,672 3,672 04 Jan 2023 Common stock, par value $0.01 per share 3,672 $135.92 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +4,592 4,592 04 Jan 2023 Common stock, par value $0.01 per share 4,592 $161.30 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +2,434 2,434 04 Jan 2023 Common stock, par value $0.01 per share 2,434 $99.21 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +6,638 6,638 04 Jan 2023 Common stock, par value $0.01 per share 6,638 $40.40 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +6,835 6,835 04 Jan 2023 Common stock, par value $0.01 per share 6,835 $57.74 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +3,229 3,229 04 Jan 2023 Common stock, par value $0.01 per share 3,229 $51.67 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +8,416 8,416 04 Jan 2023 Common stock, par value $0.01 per share 8,416 $63.51 Direct F1, F3
transaction GEHC Deferred Bonus Phantom Stock Units Award +28 28 03 Jan 2023 Common stock, par value $0.01 per share 28 Direct F1, F4, F5
transaction GEHC Restricted Stock Units Award +1,261 1,261 04 Jan 2023 Common stock, par value $0.01 per share 1,261 Direct F1, F6, F7
transaction GEHC Restricted Stock Units Award +2,599 2,599 04 Jan 2023 Common stock, par value $0.01 per share 2,599 Direct F1, F6, F8
transaction GEHC Restricted Stock Units Award +2,549 2,549 04 Jan 2023 Common stock, par value $0.01 per share 2,549 Direct F1, F6, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.
F2 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.
F3 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.
F4 Each unit of phantom stock is the economic equivalent of one share of GE HealthCare common stock.
F5 Award of phantom stock with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Payable after termination of service. This transaction is being reported notwithstanding the exemption provided by Rule 16a-9.
F6 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F7 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.
F8 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.
F9 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.